Join the club for FREE to access the whole archive and other member benefits.

Loyal

Biotechnology company developing medicines to extend dog lifespan

We are a team of veterinarians, scientists, and dog lovers devoted to developing medicines intended to treat the underlying causes of aging in dogs.

Our scientists' educational backgrounds span academic institutions including Cornell University’s College of Veterinary Medicine and Oxford University and industry expertise in developing therapeutic candidates with Regeneron and Zoetis.

Visit website: https://loyalfordogs.com/

 LoyalForDogs

 loyalfordogs

 loyalfordogs

Details last updated 25-Aug-2021

People at Loyal

Celine Halioua

CEO and founder of Loyal, interested in the biology of aging

Loyal News

New venture capital firm age1 aims to extend healthy lifespan

New venture capital firm age1 aims to extend healthy lifespan

Longevity Technology - 22-Sep-2023

Investing in the next generation of longevity biotech companies

Loyal aims for a animal pharmaceutical company to delay ageing of "man's best friend"

Loyal aims for a animal pharmaceutical company to delay ageing of "man's best friend"

TechCrunch - 23-Sep-2021

Developing therapies to extend life in dogs, and further extending the research in humans